The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Zoetis Inc

NYSE: ZTS
Last

(U.S.) $44.90

Today's change+0.29 +0.65%
Updated May 4 12:00 PM EDT. Delayed by at least 15 minutes.
 

Zoetis Inc

NYSE: ZTS
Last

(U.S.) $44.90

Today's change+0.29 +0.65%
Updated May 4 12:00 PM EDT. Delayed by at least 15 minutes.

Zoetis Inc up (U.S.)$0.29

Zoetis Inc is up today by (U.S.)$0.29 or 0.65% to (U.S.)$44.90. Shares have lost 4.12% over the last five days, but have gained 4.35% over the last year to date. This security has outperformed the S&P 500 by 33.99% during the last year.

Key company metrics

  • Open(U.S.) $44.75
  • Previous close(U.S.) $44.61
  • High(U.S.) $45.21
  • Low(U.S.) $44.71
  • Bid / Ask(U.S.) $44.89 / (U.S.) $44.90
  • YTD % change+4.35%
  • Volume1,815,177
  • Average volume (10-day)3,568,593
  • Average volume (1-month)2,902,867
  • Average volume (3-month)3,445,307
  • 52-week range(U.S.) $29.56 to (U.S.) $47.99
  • Beta--
  • Trailing P/E38.66×
  • P/E 1 year forward27.09×
  • Forward PEG3.22×
  • Indicated annual dividend(U.S.) $0.33
  • Dividend yield0.74%
  • Trailing EPS(U.S.) $1.16
Updated May 4 12:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.27%

Based on its net profit margin of 12.27%, Zoetis Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.29%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 28, 201409/28/2014Jun 29, 201406/29/2014Mar 30, 201403/30/2014
Revenue1,3201,2101,1581,097
Total other revenue--------
Total revenue1,3201,2101,1581,097
Gross profit829776745718
Total cost of revenue491434413379
Total operating expense1,165972958870
Selling / general / administrative497394396356
Research & development124939287
Depreciation / amortization14161515
Interest expense (income), net operating30292929
Unusual expense (income)137121
Other operating expenses, total-9-8-6-6
Operating income155238200227
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax155238200227
Income after tax126167139155
Income tax, total29716172
Net income126166136155
Total adjustments to net income--------
Net income before extra. items126166136155
Minority interest0-1-30
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items126166136155
Inc. avail. to common incl. extra. items126166136155
Diluted net income126166136155
Dilution adjustment------0
Diluted weighted average shares503502502501
Diluted EPS excluding extraordinary itemsvalue per share0.250.330.270.31
Dividends per sharevalue per share0.160.070.000.07
Diluted normalized EPSvalue per share0.270.340.290.31